Pharmacokinetic study of AVI 4126 [RESTEN-NG] in cerebral spinal fluid among healthy adult males following intravenous administration

Trial Profile

Pharmacokinetic study of AVI 4126 [RESTEN-NG] in cerebral spinal fluid among healthy adult males following intravenous administration

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Aug 2012

At a glance

  • Drugs AVI 4126 (Primary)
  • Indications Coronary artery restenosis
  • Focus Pharmacokinetics
  • Sponsors Sarepta Therapeutics
  • Most Recent Events

    • 14 Jul 2009 Actual end date June 2009 added as reported by ClinicalTrials.gov.
    • 17 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top